KLINISKE UNDERSØGELSER Den kliniske sikkerhed og effekt af SUTENT er undersøgt hos patienter med malign gastrointestinal stromal tumor (GIST).
CLINICAL STUDIES The clinical safety and efficacy of SUTENT has been studied in the treatment of patients with malignant gastrointestinal stromal tumour (GIST) who were resistant to imatinib (i. e. those who experienced disease